Journal article
Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
Abstract
Oncolytic virotherapy is a promising biological approach to cancer treatment that contributes to tumor eradication via immune- and non-immune-mediated mechanisms. One of the remaining challenges for these experimental therapies is the necessity to develop a durable adaptive immune response against the tumor. Vesicular stomatitis virus (VSV) is a prototypical oncolytic virus (OV) that exemplifies the multiple mechanisms of oncolysis, including …
Authors
Leveille S; Goulet M-L; Lichty BD; Hiscott J
Journal
Journal of Virology, Vol. 85, No. 23, pp. 12160–12169
Publisher
American Society for Microbiology
Publication Date
12 2011
DOI
10.1128/jvi.05703-11
ISSN
0022-538X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AnimalsAntigen PresentationAntigens, NeoplasmCell MovementCell ProliferationCombined Modality TherapyDendritic CellsFemaleFlow CytometryGenetic TherapyLymphoma, T-CellMelanoma, ExperimentalMiceMice, Inbred BALB CMice, Inbred C57BLOncolytic VirotherapySurvival RateT-LymphocytesVesicular stomatitis Indiana virusfms-Like Tyrosine Kinase 3